Laurence Fenart
Tilloy-Fenart, Laurence
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 173320947 ( Personal )
Permalink: http://viaf.org/viaf/173320947
Preferred Forms
-
100 0 _
‡a
Laurence Fenart
-
100 1 _
‡a
Tilloy-Fenart, Laurence
-
100 1 _
‡a
Tilloy-Fenart, Laurence
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers. |
|
| The blood brain barrier and ischemia : in vitro study of microvascular protection and dysfunction. |
|
| Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation. |
|
| [Cerebral transfer and neuroprotection] |
|
| Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study. |
|
| Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases |
|
| A differential proteomic approach identifies structural and functional components that contribute to the differentiation of brain capillary endothelial cells. |
|
| Down-regulation of caveolin-1 in glioma vasculature: modulation by radiotherapy. |
|
| Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier. |
|
| Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid. |
|
| Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier |
|
| An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. |
|
| In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes. |
|
| Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity |
|
| Mise en évidence d'une voie originale de transcytose à travers la barrière hémato-encéphalique in vitro : application à la vectorisation de médicaments vers le cerveau |
|
| Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. |
|
| Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. |
|
| Occurence of an original transcytotic pathway through the blood-brain barrier in vitro : a new strategy for drug delivery to the brain. |
|
| Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells. |
|
| P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. |
|
| Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. |
|
| Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. |
|
| Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. |
|
| Protein transport in cerebral endothelium. In vitro transcytosis of transferrin. |
|
| Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease. |
|
| Rôle du transporteur ABCA7 dans les mécanismes de transport du cholestérol et des peptides β-amyloïdes au niveau de la barrière hémato-encéphalique et implications dans la maladie d'Alzheimer |
|
| [Role of the blood-brain barrier in Alzheimer's disease] |
|
| Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo/in vitro study. |
|
| Transcytosis through the blood brain barrier : in vitro studies of the transport of low density lipoprotein and ß-amyloid peptide. |
|
| Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway |
|
| β-Cyclodextrins Decrease Cholesterol Release and ABC-Associated Transporter Expression in Smooth Muscle Cells and Aortic Endothelial Cells |
|
